Literature DB >> 15747125

Fibromyxoid sarcoma in a 4-year-old boy: case report and review of the literature.

G Rando1, V Buonuomo, C D'Urzo, F Vecchio, M Caldarelli, C Pintus.   

Abstract

The authors report on the case of a low-grade fibromyxoid sarcoma (LGFMS) with giant rosettes in a 4-year-old boy. The tumor arose in the paravertebral region and had infiltrated the vertebral canal between L2 and S1. A review of the literature indicates that this is one of the youngest patients diagnosed with a tumor of this type, and spinal involvement had never been reported with LGFMS.

Entities:  

Mesh：

Year:  2005        PMID： 15747125     DOI： 10.1007/s00383-005-1400-2

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN： 0179-0358            Impact factor:   1.827


  9 in total

1.  Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas.

Authors:  A L Folpe; K L Lane; G Paull; S W Weiss
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

2.  Low-grade fibromyxoid sarcoma.

Authors:  D M Devaney; P Dervan; S O'Neill; D Carney; M Leader
Journal:  Histopathology       Date:  1990-11       Impact factor: 5.087

3.  Fibromyxoid sarcoma in a four-year-old child: case report and review of the literature.

Authors:  C Canpolat; H L Evans; C Corpron; R J Andrassy; K Chan; P Eifel; O Elidemir; B Raney
Journal:  Med Pediatr Oncol       Date:  1996-12

4.  Hyalinizing spindle cell tumor with giant rosettes: a distinctive tumor closely resembling low-grade fibromyxoid sarcoma.

Authors:  K L Lane; R J Shannon; S W Weiss
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

5.  Low-grade fibromyxoid sarcoma. A report of 12 cases.

Authors:  H L Evans
Journal:  Am J Surg Pathol       Date:  1993-06       Impact factor: 6.394

6.  Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance.

Authors:  H L Evans
Journal:  Am J Clin Pathol       Date:  1987-11       Impact factor: 2.493

7.  Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t(7;16)(q34;p11) translocation.

Authors:  Robin Reid; M V Chandu de Silva; Lindsay Paterson; Eleanor Ryan; Cyril Fisher
Journal:  Am J Surg Pathol       Date:  2003-09       Impact factor: 6.394

8.  Low-grade fibromyxoid sarcoma: case report and immunohistochemical study.

Authors:  G E Nichols; P H Cooper
Journal:  J Cutan Pathol       Date:  1994-08       Impact factor: 1.587

9.  Low grade fibromyxoid sarcoma: clinicopathological analysis of eleven new cases in support of a distinct entity.

Authors:  J R Goodlad; T Mentzel; C D Fletcher
Journal:  Histopathology       Date:  1995-03       Impact factor: 5.087
  9 in total
  5 in total

1.  Primary paravertebral low-grade fibromyxoid sarcoma.

Authors:  Woo Jin Lee; Chong Oon Park; Seung Hwan Yoon; Young Chae Chu
Journal:  J Korean Neurosurg Soc       Date:  2010-11-30

2.  CT and MRI features of low-grade fibromyxoid sarcoma in the shoulder of a pediatric patient.

Authors:  Mototaka Miyake; Ukihide Tateishi; Tetsuo Maeda; Yasuaki Arai; Kunihiko Seki; Tadashi Hasegawa; Kazuro Sugimura
Journal:  Radiat Med       Date:  2006-08

3.  Low-grade fibromyxoid sarcoma, a deceptively benign tumor in a 5-year-old child.

Authors:  Seema Menon; Michael Krivanek; Ralph Cohen
Journal:  Pediatr Surg Int       Date:  2011-12-01       Impact factor: 1.827

4.  Low-grade fibromyxoid sarcoma of the hand: a case report.

Authors:  Guy Rubin; Micha Rinott; Alejandro Wolovelsky; Irit Elmalach; Nimrod Rozen
Journal:  Hand (N Y)       Date:  2010-06-16

Review 5.  Deeply located low-grade fibromyxoid sarcoma with FUS-CREB3L2 gene fusion in a 5-year-old boy with review of literature.

Authors:  Aiko Kurisaki-Arakawa; Yoshiyuki Suehara; Atsushi Arakawa; Tatsuya Takagi; Michiko Takahashi; Keiko Mitani; Kazuo Kaneko; Takashi Yao; Tsuyoshi Saito
Journal:  Diagn Pathol       Date:  2014-09-03       Impact factor: 2.644
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.